1. Introduction {#s0005}
===============

Epilepsy is the most common serious neurological disorder. It comprises a heterogeneous group of epilepsy syndromes characterized by a shared predisposition to develop unprovoked epileptic seizures ([@bb0150]). Based on the origin of seizure activity, epileptic seizures and syndromes can be focal or generalized ([@bb0040]). The underlying cause varies greatly across different epilepsy syndromes. Estimates from twin studies indicate a significant genetic role in most epilepsy syndromes ([@bb0390], [@bb0310]). Newly developed techniques to estimate heritability from dense genotype data have indicated that at least 26% of the phenotypic variation in epilepsy is collectively explained by genetic variants occurring commonly in the general population ([@bb0460]). Despite the evidence of heritability, most epilepsy-causing genetic mutations have been identified by linkage analyses in families with Mendelian patterns of inheritance, which account for \< 1% of all epilepsy syndromes. Common epilepsies often exhibit a complex or obscure inheritance pattern: causation may be attributable to multiple genetic variants interacting with each other and with environmental factors. Although steady progress is being made, the genetic determinants underlying most common epilepsy syndromes remain largely unknown.

2. Genetic studies of complex epilepsies - current constraints and limitations {#s0010}
==============================================================================

Several single-gene mutations have been linked to familial forms of epilepsy ([@bb0240]). For example, familial forms of genetic generalized epilepsies (GGEs) have been linked to mutations in the *SLC2A1* gene that encodes *GLUT1*, a cell membrane glucose transporter ([@bb0480]). Mutations in *LGI1* have been associated with familial focal epilepsies, including autosomal-dominant lateral temporal lobe epilepsy (ADLTLE) ([@bb0290]). Interestingly, pleiotropy is not uncommon: a number of genes which when mutated can cause epilepsy are associated with diverse epilepsy phenotypes. For example, mutations in the genes *SCN1A*, *SCN2A*, *SCN1B*, *KCNQ2*, *DEPDC5* and *TBC1D24* can all cause a variety of epilepsies ([@bb0180], [@bb0115], [@bb0025], [@bb0035]).

The genetic determinants of common epilepsy syndromes, where family history is lacking or suggests a complex inheritance pattern, are much less clearly defined. Their genetic architecture has been explored in many candidate gene studies, deep sequencing analyses and genome-wide association studies (GWASs; [@bb0255], [@bb0335]). Rare sequence and copy number variants of large effect have been identified in childhood absence epilepsies ([@bb0085]), GGEs ([@bb0260]) and other epilepsy phenotypes ([@bb0250], [@bb0315]). GWAS has shown that common polymorphisms have a role in complex focal epilepsies with known or suspected brain lesions ([@bb0235]), mesial temporal lobe epilepsy (MTLE) with hippocampal sclerosis ([@bb0300]) and complex generalized epilepsies ([@bb0135]). A recent meta-analysis of genome-wide data from 8696 epilepsy cases and 26,157 controls revealed two susceptibility genes, *SCN1A* and *PCDH7*, as risk loci across all forms of epilepsy, and a third risk locus (at *VRK2* or *FANCL*) for generalized forms of the disorder ([@bb0275]). Despite these promising findings, the replication rate and functional validation of susceptibility loci for complex epilepsies is poor ([@bb0335]).

Sample sizes need to be large for successful GWAS. Recent multisite collaborations, such as those led by the International League Against Epilepsy (ILAE) Consortium on Complex Epilepsies (<http://www.ilae.org/Commission/class/consortium.cfm>), address this by assembling larger cohorts of epilepsy cases and healthy controls, boosting statistical power. Even so, these genome-wide meta-analyses can aggregate data from diverse ethnic groups and samples can be clinically heterogeneous. Heterogeneity can make GWAS results harder to interpret, as the detected genome-wide signals may be driven by differences in linkage disequilibrium (LD) structure between sub-cohorts, uncontrolled effects of cryptic population stratification ([@bb0365]), synthetic associations created by rare variants ([@bb0120], [@bb0565]), or overrepresented effects from specific epilepsy subtypes or sub-cohorts. Similarly, non-significant findings may be attributed, in part, to phenotype misclassifications ([@bb0355]). GWAS will also miss any consistent effects of rare genetic variants ([@bb0185], [@bb0190]).

GWAS was initiated based on a simple *common disease-common variant* (CDCV) hypothesis, which posited that complex disorders, such as epilepsy, are largely explained by a moderate number of variants occurring commonly (\> 1%) in the general population ([@bb0075], [@bb0425], [@bb0430]). This perspective has since evolved into several diverging hypotheses. Some argue that the genetic component of a disease is mainly due to a large number of common variants of small effect (the *infinitesimal* model). Others insist that it is due to a large number of rare variants of large effect (the *rare allele* model), and others still suggest a combination of genomic, environmental and epigenetic interactions (the *broad sense heritability* model; see [@bb0190], for a review). Recent genome-wide meta-analyses have integrated the broad-sense heritability hypothesis into their statistical designs using *linear mixed models* (LMM), which restrict heritability estimates to a certain class of single nucleotide polymorphisms (SNPs) in high LD with those on genotype platforms ([@bb0575], [@bb0580]). Despite these advances, the number of novel genome-wide significant findings remains sparse, and the liability variance explained by each detected risk locus is low (often \< 1%).

Typically, common susceptibility loci captured via case: control association studies exert subtle molecular and cellular alterations with remote effects on gene transcription, protein structure, or protein function ([@bb0533]). A complex clinical phenotype, such as seizure type or epilepsy syndrome, therefore tends to be indirectly predicted by any associated genotype. Although large-scale multisite meta-analyses may boost power to detect subtle biological effects, several creative alternatives may help to sidestep the complicated phenotype integrity of common epilepsy syndromes ([@bb0410]). One widely investigated alternative is the use of intermediate quantitative traits (QTs) that may be closer to the underlying biology of the disease than the clinical phenotype. These intermediate QTs are commonly referred to as *endophenotypes*.

3. Endophenotypes - definition and criteria {#s0015}
===========================================

Endophenotypes are subclinical QTs, occupying the domain between disease phenotype and the genetic variants that influence disease risk ([@bb0215]). Unlike binary diagnostic outcomes (e.g. 'patient' versus 'healthy control'), endophenotypes are quantifiable measures that are arguably closer to the genetic architecture of a disease than its clinical manifestation (e.g., seizure semiology) ([@bb0225]). In theory, endophenotypes allow us to deconstruct phenotypically heterogeneous syndromes, including epilepsy syndromes, into phenomena more reflective of the underlying genetic architecture, improving power to detect risk genes and their functional consequences ([@bb0530]).

Several criteria have been proposed to identify valid endophenotypes, since Gottesman & Shields\' original (1973) conceptualization. Some corollaries and extensions continue to be discussed (see [@bb0385], for a review), but the following five criteria are generally accepted by the genetics community ([@bb0225], [@bb0245]). An endophenotype should be:1.Associated with illness in the relevant population2.State independent (i.e., it manifests in an individual regardless of whether an illness is active or not) and may require elicitation by a challenge (e.g., glucose tolerance test in relatives of patients with diabetes)3.Heritable4.Co-segregating with illness within families5.Present in non-affected family members at a higher rate than in the general population

In principle, endophenotypes may be biochemical, endocrinological, electrophysiological, cognitive, or anatomical in nature ([@bb0225]). A vast number of research tools have been applied to characterize relevant endophenotypes in brain-related disorders; ranging from eye movement recording ([@bb0360]), electroencephalography (EEG) and magnetic resonance imaging (MRI; [@bb0270]), to behavioral measures and neuropsychological batteries ([@bb0195], [@bb2135]). MRI is arguably one of the most easily accessible and widely employed of these techniques. Indeed, in epilepsy, a large percentage of people with epilepsy undergo brain MRI as part of their clinical evaluation to look for potential underlying structural abnormality (e.g. malformation of cortical development or tumor). Quantitative MRI (QMRI) studies of people with epilepsy have characterized a wide range of subtle structural and functional brain alterations that are associated with particular epilepsy syndromes ([@bb0400]). Some proportion of these subtle brain alterations may be due to early brain insults (e.g., central nervous system (CNS) infection or head trauma), disease-related factors (e.g. recurrent seizure activity or chronic medication use), or other environmental factors ([@bb0340]). However, genetic mechanisms may also play a role, based on growing evidence from studies of asymptomatic first-degree relatives of epilepsy sufferers ([@bb0510]).

4. QMRI traits as endophenotypes in genetic mapping studies: a promising future? {#s0020}
================================================================================

For a number of psychiatric illnesses, there is an ongoing quest to identify heritable, state-independent, neuroimaging-derived endophenotypes ([@bb0375]). For example, schizophrenia patients and their asymptomatic first-degree relatives appear to exhibit a similar pattern of brain structural alterations, including reduced prefrontal and temporal lobe grey matter (GM) volume ([@bb0080]), vertical displacement of the corpus callosum ([@bb0405]), and inward deformity at the head of the hippocampus ([@bb0490]). Similarly, in bipolar disorder, significant white matter (WM) alterations in the corpus callosum, posterior thalamic radiations and left superior longitudinal fasciculus have been reported in patients and their asymptomatic siblings ([@bb0465]). Also, in major depressive disorder, GM alterations within the ventral diencephalon have been associated, in part, with genetic risk factors ([@bb0205]). Despite limitations attributed to variable sensitivity of different image analysis techniques and modest statistical power, several of these findings have been validated using larger sample sizes and standardized image processing algorithms ([@bb0100], [@bb0470]).

Many of the proposed neuroanatomical endophenotypes show moderate-to-high heritability in healthy and affected populations ([@bb0415], [@bb0200], [@bb0210], [@bb0105]). This has led some groups to pioneer a new research paradigm - known as *imaging genomics* - whereby neuroimaging-derived endophenotypes are used as quantitative phenotypes for genome-wide genetic mapping studies ([@bb0500]). Under this imaging genomics model, a brain measure (such as the volume of a region of interest) is specified as a QT across a moderate-to-large sample of genome-wide genotyped participants. A regression model is then applied to test for an association between the additive allelic dosage of each SNP (independent variable) and the imaging phenotype of interest (dependent variable). Imaging genomics has successfully mapped the effects on the brain of a number of important genetic variants that are also associated with disease risk, sometimes using smaller samples than those required by traditional case-control association studies. In one of the first GWAS to be conducted directly on neuroimaging data, [@bb0420] analyzed genotypes and QMRI phenotype data from 381 Alzheimer\'s disease (AD) patients, collected as part of the Alzheimer\'s Disease Neuroimaging Initiative (ADNI). Although such a sample would rate as very small for a GWAS in general, the group still detected a significant association between variants in the *TOMM40* and *APOE* genes and hippocampal volume (HV) in AD ([@bb0420]). Shortly after the ADNI dataset was released to the public, over 100 discoveries were reported, relating differences in brain images to common variants in the *BIN1, CLU*, *CR1* and *PICALM* genes - all of which were corroborated by imaging, cerebrospinal fluid (CSF) markers and cognitive phenotypes (see [@bb0450], for a review).

In recent years, the field of imaging genomics has expanded into a number of multinational research networks. Some notable collaborations include the Early Growth Genetics (EGG) project, which identified a significant association between variants in the *HMGA2* gene and head circumference at birth in a cohort of over 69,000 individuals ([@bb3464]); the Enhancing Neuro Imaging through Meta-Analysis (ENIGMA) consortium (<http://enigma.ini.usc.edu>), which replicated the association between *HMGA2* and intracranial volume, in addition to identifying a novel intergenic variant associated with HV in a sample of almost 8000 adult participants ([@bb0475]); and the Cohorts of Heart and Aging Research in Genomic Epidemiology (CHARGE) group, which reported variants associated with HV reduction (including a replication of the variant identified by ENIGMA) in a sample of over 9000 elderly participants ([@bb0065]).

There has been heated debate as to whether the penetrance of genetic variants is higher for these neuroimaging-derived endophenotypes than for complex, binary diagnostic outcomes (see [Fig. 1](#f0005){ref-type="fig"}; [@bb0155]). If effect sizes are greater for common variants that affect some key imaging traits, or if less of the genome explains more of the variance, imaging genomics may offer a more efficient method to discover genes involved in different neurological or psychiatric illnesses than traditional case--control association studies ([@bb0380]). Indeed, as imaging genomics collaborations, such as the ENIGMA consortium, continue to grow their sample sizes to over 30,000 participants, the discovery rate for novel genetic loci associated with important brain regions continues to increase ([@bb0265]). The effects of loci associated with brain measures are actively being explored in many psychiatric and neurologic illnesses ([@bb0375], [@bb0435]), and in animal models ([@bb0030]). Imaging genomics in future may offer a new and powerful method to improve our understanding of epilepsy and its elusive genetic underpinnings. So far, several QMRI-based studies have attempted to validate an epilepsy-related neuroimaging endophenotype by exploring potential co-segregation of neuroanatomical and functional alterations in people with epilepsy and their asymptomatic first-degree relatives. The next section offers a comprehensive review of these investigations.

5. QMRI traits as endophenotypes for epilepsy {#s0025}
=============================================

Over the last two decades, epilepsy-related EEG and brain QMRI traits have been evaluated as possible endophenotypes. Studies that examined the endophenotypic potential of QMRI traits in epilepsy are summarized in [Table 1](#t0005){ref-type="table"}.

5.1. QMRI traits as endophenotypes for focal epilepsies {#s0030}
-------------------------------------------------------

Most studies exploring potential neuroimaging endophenotypes for epilepsy focus on focal syndromes, primarily MTLE. MTLE is the most prevalent form of medically intractable focal epilepsy. The most common pathology underlying MTLE is hippocampal sclerosis (HS), which is characterized histologically by cellular loss and synaptic reorganization within hippocampal subregions ([@bb0550]). HS can be detected using MRI in up to 70% of MTLE patients through the identification of hippocampal atrophy and signal abnormalities ([@bb0070]). The underlying etiology of HS remains a subject of debate, although the latest evidence indicates an interaction of several polygenic and environmental factors ([@bb0340]).

The heritability of HS has been examined by a number of investigators. The majority of these investigations were conducted on relatively small sample sizes. [@bb0145] investigated 23 family members of patients with MTLE associated with HS (MTLE + HS) and reported a significant hippocampal asymmetry in the asymptomatic family members who had experienced febrile seizures (FS) during childhood ([@bb0145]). Hippocampal asymmetry was also identified in up to 50% of those family members who had never experienced FS. A follow up study by [@bb0320] examined 52 asymptomatic members of 11 families of patients with MTLE + HS. Significant hippocampal atrophy was identified in up to 34% of the asymptomatic relatives ([@bb0320]). In addition, visual inspection of the T1- and T2-weighted images revealed classic MRI features of HS, including abnormal T2 signal abnormalities and altered internal structure of the hippocampus, in most of these relatives ([@bb0320]). These two studies were complemented by a more recent investigation that explored HV in 32 asymptomatic first-degree relatives of MTLE + HS patients ([@bb0510]). Here, the authors reported significantly reduced HV in the asymptomatic relatives of patients when compared to healthy controls ([@bb0510]). This trend appeared stronger in the relatives of patients with a family history of epilepsy (see [Fig. 2](#f0010){ref-type="fig"}). Contrastingly, an independent investigation of MTLE + HS patients who reported no family history of seizures (i.e., sporadic cases) and their asymptomatic siblings (*n* = 50 discordant sibling pairs) reported no significant HV deficits in the asymptomatic siblings ([@bb0015]). A trend of volume reduction was, however, noted in the hippocampus ipsilateral to the side of HS ([@bb0015]). The authors attributed these findings to the possibly limited sensitivity of their automated segmentation technique relative to standardized manual tracing methods and to the small sample size ([@bb0020]). Further evidence for the role of genetic contributions towards hippocampal structural abnormalities was recently illustrated by a study that applied T2-relaxometry to indirectly quantify the degree of hippocampal structural alteration in patients with MTLE + HS and their asymptomatic relatives ([@bb2233]). The investigators reported increased hippocampal T2-relaxometry signal in patients relative to controls, and an intermediate relaxometry value for the asymptomatic relatives of patients ([@bb2233]). Despite some inconsistencies, the findings of the above studies suggest a familial component to hippocampal structural alterations in MTLE + HS, particularly in patients with a strong family history for seizures.

Over the last two decades, collective neuroimaging evidence has pointed to widespread structural alteration in MTLE + HS, extending beyond the hippocampus and mesial temporal lobe. Regional atrophy has been described in several subcortical GM structures ([@bb0050], [@bb0370]), the ipsilateral temporal cortex ([@bb0395], [@bb0010]), and several fronto-limbic cortical regions ([@bb0305], [@bb0400], [@bb0515]), suggesting an alteration in interconnected brain regions and localized brain networks ([@bb0055]). The endophenotypic quality of these extra-hippocampal neuroanatomical alterations in MTLE has been explored by two separate studies ([@bb0015], [@bb0020]). Using an automated segmentation method, the volume of five subcortical structures (amygdala, thalamus, caudate, putamen and globus pallidus) was compared between asymptomatic siblings of MTLE + HS patients and healthy controls ([@bb0015]). No significant group differences were noted in the volume of any of the five subcortical structures, although a trend of reduced amygdalar volume was reported in the siblings of patients ([@bb0015]). In a separate investigation, temporal cortex morphology was examined in MTLE + HS patients and their siblings ([@bb0020]). A contraction in surface area was noted within the anterio-medial regions of the temporal cortex in patients and their asymptomatic siblings ([@bb0020]). Interestingly, this altered surface area pattern was observed ipsilateral to the side of HS of the affected siblings, suggesting the possibility of a common driving process. WM tract integrity was also investigated in patients with MRI-negative MTLE and their siblings using diffusion-tensor imaging (DTI; [@bb0540]). Subtle microstructural alterations of the superior longitudinal fasciculus were reported in the asymptomatic siblings in a pattern similar to that displayed by patients (see [Fig. 3](#f0015){ref-type="fig"}), highlighting the endophenotypic potential of WM microstructural alterations in MTLE ([@bb0540]). Although replication studies to validate the above findings are yet to be conducted, these results provide preliminary evidence for the eligibility of QMRI neuroanatomical traits as endophenotypes for MTLE.

5.2. QMRI traits as endophenotypes for genetic generalized epilepsies {#s0035}
---------------------------------------------------------------------

GGEs (previously known as primary generalized epilepsies or idiopathic generalized epilepsies) refer to a group of characteristic epilepsy syndromes with a known or presumed genetic defect in the absence of either structural brain abnormality or an acquired pathology ([@bb0040], [@bb0175]). Although the biological basis of the majority GGE syndromes remains unknown, evidence from EEG and neuroimaging studies suggests a link to disruptions in thalamo-frontal brain networks ([@bb0130]). Juvenile myoclonic epilepsy (JME) is the most common of the GGEs; accounting for 5% to 10% of all epilepsies. Although visual inspection of routine brain MRI in JME patients reveals no visible abnormality, QMRI studies have detected several subtle neuroanatomical abnormalities, such as thalamic volume loss and increased mesio-frontal and frontobasal GM concentration ([@bb0555], [@bb0060], [@bb0015]). These observations have been supported by positron emission tomography (PET) and proton magnetic resonance spectroscopy studies ([@bb0345]), indicating that the underlying mechanisms in JME may relate to aberrant frontothalamic structure ([@bb0130]). Nonetheless, a clear set of GGE-specific neuroanatomical markers has not yet been fully characterized, and the endophenotypic property of frontothalamic alterations remains to be determined.

Recently, [@bb0535] applied functional MRI to explore the endophenotypic theory in JME ([@bb0535]). In this study, brain activation during a working memory task was compared between 15 asymptomatic siblings of JME patients and 20 healthy controls. Abnormal primary motor cortex and supplementary motor area co-activation was noted in the asymptomatic siblings when compared to controls. This was consistent with a report of similar abnormal pattern of activation in JME patients using the same memory task ([@bb0520]), suggesting that abnormal motor cortex connectivity may represent a familial trait in JME. Although the specificity of this trait to JME was questioned ([@bb0045]), the study was the first to explore the applicability of QMRI to identify endophenotypes in GGEs.

6. Discussion {#s0040}
=============

The field of imaging genomics has expanded significantly over the last decade. Its application in epilepsy holds much promise. Characterizing epilepsy-relevant neuroimaging endophenotypes represents the first step towards expediting this research field. Unraveling the genetic determinants of relevant neuroimaging traits will undoubtedly provide valuable insight into the underlying mechanisms of the common epilepsy syndromes.

In [Section 5](#s0025){ref-type="sec"}, we discussed a number of neuroimaging traits that may fulfill the criteria of an endophenotype for two epilepsy syndromes, MTLE and JME. Additional studies using larger sample sizes will help validate these traits as intermediate phenotypes for future genetic mapping efforts. At present, HV in MTLE + HS appears to be the most promising neuroimaging endophenotype in epilepsy. Mapping the genetic determinants of HV in patients with MTLE + HS could unravel novel genetic variants linked to the pathogenesis of MTLE + HS. It is important to recognize, however, that the eligibility of HV as an endophenotype for MTLE + HS could be compromised by the impact of many significant environmental factors ([@bb0005]). Early brain insults (such as atypical FS, CNS infection, and significant head injury) are known risk factors for hippocampal damage and MTLE + HS ([@bb0445], [@bb0340]). In addition, the impact of epilepsy chronicity on hippocampal structure, including the effect of recurrent seizure activity, needs consideration ([@bb0165]). Nevertheless, some early insults, such as FS, could be genetically mediated and exploring their role in epilepsy predisposition is crucial ([@bb0140]). The potential limitation of environmental factors could be addressed by mapping HV genetic determinants in healthy human populations to indirectly inform on the genetic underpinnings of HV loss in MTLE + HS. An example of this approach is currently underway through collaboration between the ILAE and ENIGMA consortium ([@bb0545]).

Another important point to consider is the specificity of HV as an imaging trait for MTLE + HS. Hippocampal atrophy is associated with many other brain-related conditions such as AD ([@bb0280]). Further, reduced HV has been described in patients with schizophrenia ([@bb0570]), depression ([@bb0325]), and post-traumatic stress disorder ([@bb0295]). Identifying genetic variants that influence HV is less likely to elucidate susceptibility variants unique to each brain condition, but may provide an opportunity to characterize biological pathways shared by such complex brain-related disorders, which themselves may be co-morbid. Shared underlying mechanisms between epilepsy and other neurologic and psychiatric disorders, including genetic processes, have been suggested by the observation that epileptic seizures form part of the wide phenotype of some brain-related conditions, such as autism spectrum disorder ([@bb0691]).

Over the last two decades, the search for neuroimaging endophenotypes has expanded. In addition to volumetric and functional QMRI, several research groups have examined cerebral cortex morphometry (e.g., cortical thickness and folding patterns), subcortical shape, and high-angular resolution DTI parameters as alternative approaches to characterize sensitive neuroimaging QTs. Many of these advanced techniques have been applied in epilepsy populations ([@bb0160], [@bb0455], [@bb0400], [@bb0515], [@bb0330]), but they have yet to be utilized to validate suitable endophenotypes. Alternative subclinical traits have also shown promising results. For example, the photoparoxysmal response (PPR) - an abnormal EEG trait that is provoked by intermittent photic stimulation and marked by diffuse paroxysmal discharges recorded as spike-wave complexes - is observed in up to 15% of GGEs and 40% of JME patients ([@bb0560], [@bb0230], [@bb0505]). PPR has shown 100% concordance in monozygotic twins and a sibling recurrence risk of 20--30% ([@bb0125], [@bb0485]). Interestingly, associations between PPR and candidate genes, including *NEDD4-22*, *TRPC4* and *BRD2*, have previously been established ([@bb0350], [@bb0110], [@bb0525]). Although a PPR gene has yet to be identified for common forms of epilepsy ([@bb7436]), this EEG trait is associated with de novo mutations in the *CHD2* gene, which also confer risk for rare forms of photosensitive epilepsy ([@bb0495], [@bb0170]). EEG-based topological network measures have also shown a potential genetic basis in epilepsy populations. For example, GGE patients and their asymptomatic relatives show greater *mean degree* (mean number of connections between nodes in a brain network) and *degree distribution* variance (probability distribution of connections between nodes in a brain network) compared to healthy controls in the 6--9 Hz band, suggesting possible co-segregation of abnormal brain network properties ([@bb0090]). Finally, evidence of a parallel profile of cognitive deficits has been reported in GGE patients and their first-degree relatives, with both groups showing impairments in nonverbal reasoning, verbal generativity, working memory and sustained attention ([@bb0095]).

As international collaborations such as the ILAE Consortium on Complex Epilepsies (<http://www.ilae.org/Commission/class/consortium.cfm>) continue to boost power to detect common genetic variants associated with common epilepsy syndromes, the traditional genome-wide genetic mapping approach may remain constrained by phenotypic heterogeneity, replicability issues and inevitable debates concerning missing heritability. This review discusses promising alternatives to the traditional clinical phenotypes historically employed by GWAS. Collective evidence from QMRI, EEG, and neuropsychology studies indicates the potential utility of several subclinical QTs as sensitive endophenotypes for particular epilepsy syndromes. Amongst these traits, QMRI-derived measures may serve as the most accessible and relevant endophenotypes for epilepsy. As the fields of neuroimaging and human genetics continue to advance, it is our hope that these intermediate phenotypes continue to be explored and, eventually, employed as useful tools in our continuing investigation of this highly complex neurological disorder.

This review was supported in part by a Consortium grant (U54 EB020403) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative, including the NIBIB.

![The maximum effect sizes for the top individual common genetic variants (both for discovery and replication samples) from genome-wide association studies of brain structure (for example, hippocampal volume), schizophrenia (using traditional case:control design), and other anthropomorphic traits including height and educational attainment are shown ([@bb0155]). For quantitative traits, effect sizes were measured in percent variance explained. For disease categories, effect sizes were measured in percent variance explained on the liability scale. \[Image is reproduced with permission from nature publishing group (*Nature Neuroscience*, 2016)\].](gr1){#f0005}

![The distribution of hippocampal volume in the asymptomatic relatives of MTLE + HS patients and healthy controls is displayed ([@bb0510]). (A): The symptomatic relatives (red) had smaller hippocampal volume relative to the healthy controls (blue). The same data is displayed in (B), with 90% confidence ellipse of the controls displayed in the blue oval, and 90% confidence ellipse of the relatives of probands with a positive family history (FH) displayed in the red oval. \[Image is reproduced with permission from Wolters Kluwer Health, Inc. (*Neurology*, 2013)\]. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr2){#f0010}

![Whole-brain, voxel-wise comparisons of brain diffusion tensor imaging (DTI) measures, including fractional anisotropy (FA) and mean diffusivity (MD), in a group of patients with MRI-negative mesial temporal lobe epilepsy (MTLE), their asymptomatic siblings and healthy controls are shown ([@bb0540]). Patients with MTLE demonstrated patterns of reduced FA (illustrated in red) in voxel clusters encompassing the corpus callosum, ipsilateral anterior thalamic radiation, ipsilateral corticospinal tract (CST), bilateral superior longitudinal fasciculi (SLF), and bilateral inferior longitudinal fasciculi (ILF) compared to healthy controls. The asymptomatic siblings did not show significant FA compromise when compared to the same controls. Compared to controls, MTLE patients exhibited patterns of increased MD across the SLF bilaterally and the CST ipsilaterally (illustrated in blue). Similar patterns of increased MD along the ipsilateral SLF and ipsilateral CST (illustrated in yellow) were noted in the asymptomatic siblings. \[Image is reproduced with permission from John Wiley and Sons (*Epilepsia*, 2015)\]. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr3){#f0015}

###### 

A summary of QMRI studies that investigated first-degree relatives of people with epilepsy (1998--2016).

Table 1

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author                            Year    Sample                                                                                       Method                                                                                                   Findings                                                                                                                                                                                                                                                                                                                                                                                                                                      Comment
  --------------------------------------- ------- -------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Focal epilepsies                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Alhusaini                               2016    -50 patients with MTLE + HS-50 asymptomatic siblings of patients-40 healthy controls         Surface-based morphometry (FreeSurfer) was applied to characterize temporal cortex morphology features   Altered temporal cortex morphology was identified in patients ipsilaterally within the anterio-medial temporal regions, including the entorhinal cortex, parahippocampal gyrus, and temporal pole. Subtle but similar pattern of morphology change was also noted in the asymptomatic siblings. This localized morphology alteration was related to volume loss that appeared driven by shared contraction in cerebral cortex surface area.   MTLE + HS patients and their asymptomatic siblings share a common pattern of temporal cortex morphologic alteration.

  Whelan                                  2015a   -25 patients with sporadic MRI-negative MTLE patients-25 asymptomatic siblings-60 controls   DTI whole-brain voxel-wise statistics and deterministic tractography                                     Significant FA reductions in the corpus callosum (CC), bilateral superior longitudinal fasciculi (SLF), bilateral inferior longitudinal fasciculi (ILF), and ipsilateral corticospinal tract (CST) were noted in patients only. MD increases were observed in MTLE patients and their asymptomatic siblings in the ipsilateral SLF and CST.                                                                                                   SLF and CST microstructural alterations in patients with MRI-negative MTLE may partly be influenced by genetic factors.

  Suemitsu                                2014    -26 patients with FMTLE-9 asymptomatic relatives-40 controls                                 The degree of hippocampal T2 relaxometry changes was examined                                            In a cross-sectional design, elevated T2 relaxometry was identified in patients and intermediate values were noted in the asymptomatic relatives compared to controls.\                                                                                                                                                                                                                                                                       Genetic factors may be involved in the development of some mild hippocampal abnormalities in FMTLE.
                                                                                                                                                                                                                                                        A longitudinal follow up over a mean of 4.4 year revealed significant increase in T2 relaxometry of the ipsilateral hippocampus exclusively in patients. With recurrent seizures                                                                                                                                                                                                                                                              

  Tsai                                    2013    -32 asymptomatic first-degree relatives of MTLE + HS patients-32 controls                    Manual hippocampal volumetry                                                                             Mean hippocampal volume was smaller in the asymptomatic relatives compared to controls. Additionally, the asymptomatic relatives had more asymmetric hippocampi. This effect was greater in relatives of probands with a positive family history of epilepsy.                                                                                                                                                                                 Small asymmetric hippocampi in healthy relatives of patients could represent a familial developmental variant that may predispose to the formation of MTLE + HS.

  Alhusaini                               2013    -101 'sporadic' MTLE patients-83 asymptomatic siblings of patients-86 controls               FreeSurfer (an automated segmentation tool)                                                              Volume deficits across the ipsilateral hippocampus, amygdala and thalamus were noted in MTLE + HS patients but not MRI-negative MTLE. These volume deficits were not present in the asymptomatic siblings of MTLE + HS patients.                                                                                                                                                                                                              Volume deficits for many subcortical structures in 'sporadic' MTLE + HS are largely driven by acquired factors.

  [@bb0440]                               2013    -28 MTLE + HS patients-12 asymptomatic siblings of patients-28 controls                      FreeSurfer                                                                                               A significant volume deficit in cerebral WM was common to patient and their siblings.                                                                                                                                                                                                                                                                                                                                                         Cerebral WM volume deficit is common to MTLE + HS patients and their siblings.

  Kobayashi                               2002    -52 asymptomatic individuals from 11 families with FMTLE-30 controls                         Manual hippocampal volumetry                                                                             Hippocampal atrophy was identified in 18 of 52 first-degree relatives of patients. Visual analysis of T1- and T2-weighted images showed additional classic MRI signs of HS in 14 of these 18 individuals                                                                                                                                                                                                                                      HS in FMTLE is influenced by a significant genetic predisposition.

  [@bb0285]                               1998    -three monozygous (MZ) twin pairs discordant for MTLE + HS-30 controls                       Manual hippocampal volumetry                                                                             HS was not identified in the unaffected twin using visual, volumetric, and T2 relaxometry criteria                                                                                                                                                                                                                                                                                                                                            The absence of HS in the unaffected twin is arguing against a strictly genetic hypothesis for HS.

  Fernández                               1998    -23 members of two families of patients with MTLE + HS (13 had experienced FS)-23 controls   Manual hippocampal volumetry: the right/left ratios of hippocampal volumes (RHV)                         All subjects with febrile convulsions who did not develop epilepsy and six clinically asymptomatic relatives showed asymmetric HV but normal hippocampal signal intensity.                                                                                                                                                                                                                                                                    A subtle, pre-existing hippocampal alteration may predispose to febrile convulsions and contribute to the development of subsequent HS.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Genetic generalized epilepsies (GGEs)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Wandschneider                           2014    -15 asymptomatic siblings of JME patients-20 controls                                        fMRI was applied to record brain activation during a working memory paradigm                             The asymptomatic siblings of patients showed abnormal primary motor cortex and supplementary motor area co-activation with increasing cognitive load, as well as increased task-related functional connectivity between motor and prefrontal cognitive networks                                                                                                                                                                               Altered motor system activation and functional connectivity may represents a potential familial trait for JME
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: These authors contributed equally to this review.
